3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
2
Completed
1
Sponsor Class
OTHER
3
NIH
2
INDUSTRY
2
NETWORK
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
4
Thoracic
3
Plasma cell
3
Lymphoid
3
CNS
3
Myeloid
2
Dermatologic
2
Breast
2
Other
1
Gynecologic
1
Genitourinary
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1734
Lymphoma
1731
Lymphoma, Non-Hodgkin
1205
Leukemia, Lymphocytic, Chronic, B-Cell
1120
Lymphoma, Follicular
1069
Lymphoma, Large B-Cell, Diffuse
1061
Hodgkin Disease
906
Leukemia
877
Lymphoma, Mantle-Cell
738
Leukemia, Myeloid, Acute
662
Burkitt Lymphoma
604
Multiple Myeloma
557
Lymphoma, B-Cell, Marginal Zone
546
Myelodysplastic Syndromes
507
Recurrence
451
Lymphoma, B-Cell
415
Lymphoma, Large-Cell, Immunoblastic
328
Waldenstrom Macroglobulinemia
323
Lymphoma, T-Cell, Cutaneous
322
Mycosis Fungoides
277
Neoplasms
257
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
249
Myeloproliferative Disorders
249
Neoplasms, Plasma Cell
242
Sezary Syndrome
231
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
221
Lymphoma, Large-Cell, Anaplastic
215
Leukemia, Myeloid, Accelerated Phase
211
Lymphoma, T-Cell, Peripheral
205
Blast Crisis
203
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Autoimmune Diseases
×
Lymphoid
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled
NCT01758042
2026-03-06
BMT
Massachusetts General Hospital
Phase NA
Completed
10 enrolled
NCT06416267
2024-05-16
MBL RiskConseq
University of Haifa
Not yet recruiting
1,500 enrolled